FantasticSearch

1. The Science and Innovation Panel shall advise the Governing Board on matters relevant to the research and innovation activities of the Innovative Health Initiative Joint Undertaking in accordance with Article 21.

2. The Science and Innovation Panel shall be composed of the following permanent panellists:

(a) two representatives of the Commission on behalf of the Union;

(b) four representatives of the members other than the Union;

(c) two representatives of the states’ representatives group;

(d) four representatives of the scientific community, appointed by the Governing Board following an open selection process in accordance with Article 21(4);

(e) up to six other permanent panellists, appointed by the Governing Board following an open selection process in application of Article 21(4), ensuring in particular appropriate representation of stakeholders involved in health care, covering in particular the public sector, including regulatory bodies, patients and end-users in general.

3. The permanent panellists referred to in paragraph 2, points (a), (b) and (c), may invite ad hoc panellists where appropriate to discuss specific subjects. They may jointly invite a maximum of six ad hoc panellists for each meeting. Such ad hoc panellists shall be invited based on their scientific or technical expertise on the subjects to be discussed at given meetings or taking into account the need to create synergies with other research programmes. The permanent panellists referred to in paragraph 2, points (a), (b) and (c), shall invite ad hoc panellists consensually. They shall communicate their decisions to the Governing Board, the states’ representatives group and the other permanent panellists.

4. In addition to Article 21(7), the Science and Innovation Panel shall provide advice to the Governing Board, at its request or on its own initiative, on scientific and technological matters related to the Innovative Health Initiative Joint Undertaking’s objectives, in particular about:

(a) scientific priorities, including in the context of updating the Strategic Research and Innovation Agenda;

(b) the draft work programme, including the content of calls for proposals;

(c) the planning of additional activities of members other than the Union referred to in Article 120;

(d) the set-up of advisory groups focused on specific scientific priorities in accordance with Article 17(2), point (x), and following an open selection process for their members in accordance with Article 21(4);

(e) creation of synergies with other Horizon Europe activities, including other European partnerships, as well as other Union funding programmes and national funding programmes.

5. In addition to Article 21(5), the Science and Innovation Panel shall elect its chair among the representatives provided in paragraph 2, point (d), of this Article.